[Hyperlipidemia and drug treatment].
Mimura
K
K
Third Department of Internal Medicine, Wakayama Medical University.
Yukawa
S
S
D001161:Arteriosclerosis / Q000188:drug therapy*; D002331:Carnitine / Q000627:therapeutic use; D002792:Cholestyramine Resin / Q000627:therapeutic use*; D005921:Glomerulonephritis / Q000150:complications; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy*; D007676:Kidney Failure, Chronic / Q000150:complications; D009531:Niceritrol / Q000627:therapeutic use; D010204:Pantetheine / Q000627:therapeutic use; D017035:Pravastatin / Q000627:therapeutic use; D011341:Probucol / Q000627:therapeutic use; D014810:Vitamin E / Q000627:therapeutic use
D002792:Cholestyramine Resin; D014810:Vitamin E; D010204:Pantetheine; D009531:Niceritrol; D017035:Pravastatin; D011341:Probucol; D002331:Carnitine